Jefferies Group’s Kite Pharma, Inc. KITE Stock Holding History

Jefferies Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-31,800	Closed	-$1.78M	–	2661
2016 Q3	$1.78M	Buy	+31,800	New	+$1.77M	0.01%	983
2016 Q1	–	Sell	-56,700	Closed	-$3.49M	–	2773
2015 Q4	$3.49M	Buy	56,700 +30,500	+116%	+$2.15M	0.02%	610
2015 Q3	$1.46M	Buy	+26,200	New	+$1.65M	0.01%	1038

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Jefferies Group's KITE Position: Q4 2016 in Review

Jefferies Group sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 5,600 shares — an estimated $313K sold.

Jefferies Group first reported a position in KITE in Q3 2015 and held it in 3 quarters. The position peaked at $3.66M in Q3 2015. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Jefferies Group reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Jefferies Group sold 5,600 Kite Pharma, Inc. shares in Q4 2016, an estimated $313K.
Jefferies Group first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 3 quarters.
Jefferies Group's Kite Pharma, Inc. position peaked at $3.66M in Q3 2015.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Jefferies Group's 13F filing for Q4 2016, filed 14 Feb 2017.